SANOFI (SAN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock
80.78 EUR
-0.85 (-1.04%)
Overall SAN gets a fundamental rating of 5 out of 10. We evaluated SAN against 53 industry peers in the Pharmaceuticals industry. While SAN is still in line with the averages on profitability rating, there are concerns on its financial health. SAN is not valued too expensively and it also shows a decent growth rate. Finally SAN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- In the past year SAN was profitable.
- In the past 5 years SAN has always been profitable.
- In the past 5 years SAN always reported a positive cash flow from operatings.
1.2 Ratios
- SAN has a Return On Assets of 10.63%. This is in the better half of the industry: SAN outperforms 77.36% of its industry peers.
- Looking at the Return On Equity, with a value of 18.84%, SAN is in the better half of the industry, outperforming 66.04% of the companies in the same industry.
- SAN has a better Return On Invested Capital (13.40%) than 67.92% of its industry peers.
- SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 14.02%.
- The last Return On Invested Capital (13.40%) for SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROIC | 13.4% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
- SAN has a Profit Margin of 20.63%. This is in the better half of the industry: SAN outperforms 79.25% of its industry peers.
- In the last couple of years the Profit Margin of SAN has grown nicely.
- SAN has a Operating Margin (23.61%) which is in line with its industry peers.
- SAN's Operating Margin has improved in the last couple of years.
- The Gross Margin of SAN (72.29%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SAN is still creating some value.
- SAN has about the same amout of shares outstanding than it did 1 year ago.
- SAN has about the same amout of shares outstanding than it did 5 years ago.
- The debt/assets ratio for SAN has been reduced compared to a year ago.
2.2 Solvency
- A Debt/Equity ratio of 0.18 indicates that SAN is not too dependend on debt financing.
- SAN's Debt to Equity ratio of 0.18 is amongst the best of the industry. SAN outperforms 81.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACC1.76
WACC7.62%
2.3 Liquidity
- A Current Ratio of 1.06 indicates that SAN should not have too much problems paying its short term obligations.
- The Current ratio of SAN (1.06) is worse than 67.92% of its industry peers.
- A Quick Ratio of 0.30 indicates that SAN may have some problems paying its short term obligations.
- With a Quick ratio value of 0.30, SAN is not doing good in the industry: 86.79% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 |
3. Growth
3.1 Past
- The earnings per share for SAN have decreased by -5.35% in the last year.
- SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
- Looking at the last year, SAN shows a small growth in Revenue. The Revenue has grown by 2.56% in the last year.
- The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
- The Earnings Per Share is expected to grow by 7.41% on average over the next years.
- SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.47% yearly.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 10.63 indicates a reasonable valuation of SAN.
- Based on the Price/Earnings ratio, SAN is valued cheaply inside the industry as 88.68% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 27.54, SAN is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 9.50, the valuation of SAN can be described as reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of SAN indicates a rather cheap valuation: SAN is cheaper than 86.79% of the companies listed in the same industry.
- SAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.63 | ||
| Fwd PE | 9.5 |
4.2 Price Multiples
- 75.47% of the companies in the same industry are more expensive than SAN, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.89 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of SAN may justify a higher PE ratio.
PEG (NY)4.48
PEG (5Y)2.09
EPS Next 2Y5.23%
EPS Next 3Y5.91%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 4.73%, SAN is a good candidate for dividend investing.
- SAN's Dividend Yield is rather good when compared to the industry average which is at 1.72. SAN pays more dividend than 92.45% of the companies in the same industry.
- SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.73% |
5.2 History
- The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- SAN pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
- The dividend of SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.36%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPA:SAN (1/16/2026, 5:36:15 PM)
80.78
-0.85 (-1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap196.21B
Revenue(TTM)66.91B
Net Income(TTM)13.80B
Analysts79.31
Price Target106.44 (31.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.73% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-1.1%
PT rev (3m)-2.94%
EPS NQ rev (1m)-1.79%
EPS NQ rev (3m)-10.16%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.63 | ||
| Fwd PE | 9.5 | ||
| P/S | 2.93 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.68 | ||
| P/tB | 44.63 | ||
| EV/EBITDA | 10.89 |
EPS(TTM)7.6
EY9.41%
EPS(NY)8.5
Fwd EY10.53%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.54
BVpS30.16
TBVpS1.81
PEG (NY)4.48
PEG (5Y)2.09
Graham Number71.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROCE | 16.17% | ||
| ROIC | 13.4% | ||
| ROICexc | 14.75% | ||
| ROICexgc | 65.74% | ||
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% | ||
| FCFM | N/A |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.68 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC7.62%
ROIC/WACC1.76
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
EBIT growth 1Y9.12%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y10.5%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SAN.PA FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SAN.PA) has a profitability rating of 6 / 10.
What is the valuation of SANOFI based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 10.63 and the Price/Book (PB) ratio is 2.68.
How financially healthy is SANOFI?
The financial health rating of SANOFI (SAN.PA) is 3 / 10.